News > Serum Institute of India launches world’s most affordable pneumococcal conjugate vaccine

Serum Institute of India launches world’s most affordable pneumococcal conjugate vaccine

Serum Institute of India (SII) on December 28 announced the launch of the world’s most affordable pneumococcal conjugate vaccine (PCV) in India. The vaccine provides protection against 10 variants of pneumococcus bacteria that causes pneumonia, meningitis, ear, and blood infections in children.

Pneumococcal conjugate vaccine is imported and sold in India by Pfizer and GSK. SII has priced the PCV branded as Pneumosil at $3 per dose for the public market.